Demystifying Artificial Intelligence: Key Concepts with Examples in Rheumatology

Clinical Snapshot

Key Findings

• P Value: Not reported — no hypothesis testing performed

• Effect Size: Not applicable — no quantitative effect estimates reported; this is a narrative educational review

• Primary Outcome: Conceptual synthesis: definition of core AI terminology, description of major machine learning paradigms (supervised, unsupervised, reinforcement learning, and potentially deep learning), and illustration of AI analytical methods through rheumatology-specific clinical examples

• Nnt Or Sensitivity: Not applicable — no diagnostic, therapeutic, or prognostic outcome data reported; educational impact metrics are not provided

• Confidence Interval: Not reported — no primary data analysis conducted

Clinical Application

The educational content is directly applicable to clinical practice development and continuing professional education. Feasibility of implementing AI tools described within the review will vary considerably depending on institutional infrastructure, data governance frameworks, and availability of validated commercial or research-grade AI platforms. No specific implementation pathway or resource requirement is described in the abstract. Australian rheumatologists practising under RACGP and Australian Rheumatology Association (ARA) frameworks will find this review relevant as the TGA has begun developing regulatory pathways for Software as a Medical Device (SaMD), including AI-driven diagnostic and decision-support tools. The Australian Digital Health Agency's national digital health strategy emphasises AI integration, and the My Health Record system provides a potential data substrate for AI applications in chronic disease management including rheumatoid arthritis, lupus, and gout. PBS-listed biologics and targeted synthetic DMARDs for conditions such as rheumatoid arthritis and psoriatic arthritis represent high-cost therapeutic decisions where AI-assisted treatment response prediction could have significant health economic implications. However, no AI-driven rheumatology decision-support tools are currently PBS-subsidised or TGA-approved as primary diagnostic instruments, and Australian clinicians should apply appropriate caution regarding the clinical validation status of tools described in educational reviews of this nature. Rheumatologists, rheumatology trainees, allied health professionals working in rheumatology, and clinical researchers seeking foundational literacy in AI methods as applied to musculoskeletal and autoimmune disease contexts

Abstract

Artificial intelligence (AI) refers to a broad class of computational methods to perform tasks that typically require human intelligence, such as learning patterns, reasoning, and problem solving. AI is increasingly applied across rheumatology research and clinical practice to analyze complex data and support clinical decision-making, yet its underlying concepts are often perceived as opaque or inaccessible. This aim of this article is to demystify foundational AI concepts by defining core terminology and describing major learning paradigms and analytical methods, highlighted through clinically relevant examples from rheumatology. We explain how modern AI models differ from traditional analytical approaches.

References

1. 1.Collins, J. E., Harari, R., & Duryea, J. (2026). Demystifying artificial intelligence: Key concepts with examples in rheumatology. Rheumatic Diseases Clinics of North America. Advance online publication. https://doi.org/10.1016/j.rdc.2026.04.001